Docs want more info, less rep chat

Share this article:
The results of a recent study revealed that doctors want more clinical information from drug reps but want to spend less time interacting with them.

 An analysis by management consulting firm, Oliver Wyman, indicated that physicians are skeptical of sales reps, and are unwilling to meet with them for more than a minute. The study, A Prescription for Change: The Future Go-To-Market Model for the Pharmaceutical Industry, concluded that only 56% of physicians are willing to meet with sales reps and only 24% of docs want to spend more than two minutes with a rep. Also, 86% of docs believe that the info sales reps share is, at best, biased and not completely factual.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Headliner: Ipsen head leads continental charge

Headliner: Ipsen head leads continental charge

"When I look at the business, I actually see patients in my mind. I don't see numbers."

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets